Changelog
Every shortage begun, resolved, or quietly removed — detected by daily snapshot diffs. Subscribe via RSS, or follow just one therapeutic area:
Analgesia/Addiction · Anesthesia · Anti-Infective · Antiviral · Cardiovascular · Dermatology · Endocrinology/Metabolism · Gastroenterology · Hematology · Inborn Errors · Medical Imaging · Musculoskeletal · Neurology · Oncology · Ophthalmology · Other · Psychiatry · Pulmonary/Allergy · Renal · Reproductive · Rheumatology · Transplant · Urology
2026-10-08
- Paricalcitol Capsule was removed from the FDA list (was being discontinued)
- Cobicistat Tablet was removed from the FDA list (was being discontinued)
- Felodipine Tablet, Film Coated, Extended Release appeared on the FDA shortage list (being discontinued)
- Felodipine Tablet, Extended Release appeared on the FDA shortage list (being discontinued)
2026-10-07
- Sterile Water Irrigant: availability wording revised for 2 presentation(s)
- Ifosfamide Injection: availability wording revised for 1 presentation(s)
- Clindamycin Phosphate Injection: availability wording revised for 1 presentation(s)
- Lidocaine Hydrochloride Injection: availability wording revised for 2 presentation(s)
- Furosemide Injection: availability wording revised for 1 presentation(s)
- Midazolam Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Dextrose Monohydrate 5% Injection: availability wording revised for 2 presentation(s)
2026-10-06
2026-10-03
- Technetium TC-99M Pyrophosphate Kit Injection: availability wording revised for 1 presentation(s)
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet: availability wording revised for 1 presentation(s)
- Methylphenidate Hydrochloride Tablet, Extended Release: availability wording revised for 2 presentation(s)
2026-10-02
- Hydrochlorothiazide; Quinapril Hydrochloride Tablet was removed from the FDA list (was being discontinued)
- Oseltamivir Phosphate Capsule was removed from the FDA list (was being discontinued)
- Bumetanide Injection: availability wording revised for 12 presentation(s)
- Bumetanide Injection: in shortage → resolved
- Dexmedetomidine Hydrochloride Injection: availability wording revised for 1 presentation(s)
2026-09-30
- Tafamidis Meglumine Capsule was removed from the FDA list (was being discontinued)
- Triazolam Tablet was removed from the FDA list (was being discontinued)
- Fondaparinux Sodium Injection was removed from the FDA list (was being discontinued)
- Ivermectin Tablet appeared on the FDA shortage list (being discontinued)
2026-09-26
- Fentanyl Citrate Injection: availability wording revised for 2 presentation(s)
- Hydromorphone Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Morphine Sulfate Injection: availability wording revised for 1 presentation(s)
- Sodium Bicarbonate Injection: availability wording revised for 1 presentation(s)
- Midazolam Hydrochloride Injection: availability wording revised for 2 presentation(s)
2026-09-24
- Epinephrine Bitartrate, Lidocaine Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Midazolam Hydrochloride Injection: availability wording revised for 1 presentation(s)
2026-09-23
- Pilocarpine Hydrochloride Tablet was removed from the FDA list (was being discontinued)
- Obeticholic Acid Tablet was removed from the FDA list (was being discontinued)
- Furosemide Oral Solution: availability wording revised for 2 presentation(s)
- Technetium TC-99M Pyrophosphate Kit Injection: availability wording revised for 1 presentation(s)
- Promethazine Hydrochloride Injection: availability wording revised for 3 presentation(s)
- Rivaroxaban For Suspension appeared on the FDA shortage list (being discontinued)
- Ketorolac Tromethamine Injection: availability wording revised for 3 presentation(s)
- Methylprednisolone Acetate Injection: availability wording revised for 1 presentation(s)
- Fentanyl Citrate Injection: availability wording revised for 1 presentation(s)
- Dextrose Monohydrate 70% Injection: availability wording revised for 1 presentation(s)
- Clindamycin Phosphate Injection: availability wording revised for 3 presentation(s)
- Lidocaine Hydrochloride Injection: availability wording revised for 2 presentation(s)
- Morphine Sulfate Injection: availability wording revised for 2 presentation(s)
- Dextrose Monohydrate 10% Injection: availability wording revised for 1 presentation(s)
- Bumetanide Injection: availability wording revised for 2 presentation(s)
2026-09-19
- Desonide Lotion was removed from the FDA list (was being discontinued)
- Fluphenazine Hydrochloride Tablet was removed from the FDA list (was being discontinued)
- Rivastigmine Film, Extended Release appeared on the FDA shortage list (being discontinued)
2026-09-18
2026-09-17
- Melphalan Hydrochloride Injection appeared on the FDA shortage list (being discontinued)
- Morphine Sulfate Injection: availability wording revised for 1 presentation(s)
- Methotrexate Sodium Injection: availability wording revised for 1 presentation(s)
- Fentanyl Citrate Injection: availability wording revised for 1 presentation(s)
- Epinephrine Bitartrate, Lidocaine Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Methylphenidate Hydrochloride Tablet, Extended Release: availability wording revised for 2 presentation(s)
- Desmopressin Acetate Spray: availability wording revised for 1 presentation(s)
- Lidocaine Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Hydromorphone Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet: availability wording revised for 1 presentation(s)
- Midazolam Hydrochloride Injection: availability wording revised for 2 presentation(s)
- Dextrose Monohydrate 5% Injection: availability wording revised for 1 presentation(s)
2026-09-16
2026-09-15
- Sufentanil Citrate Injection: availability wording revised for 1 presentation(s)
- Micafungin Sodium Injection appeared on the FDA shortage list (being discontinued)
- Meperidine Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Dopamine Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Midazolam Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Hydromorphone Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Sterile Water Injection: availability wording revised for 1 presentation(s)
- Heparin Sodium Injection: availability wording revised for 2 presentation(s)
2026-09-12
- Homatropine Methylbromide and Hydrocodone Bitartrate Syrup was removed from the FDA list (was being discontinued)
- Oxycodone Hydrochloride Oral Solution was removed from the FDA list (was being discontinued)
- Gemcitabine Hydrochloride Injection was removed from the FDA list (was being discontinued)
- Dextrose Monohydrate 50% Injection: availability wording revised for 2 presentation(s)
- Sodium Bicarbonate Injection: availability wording revised for 6 presentation(s)
- Atropine Sulfate Injection: availability wording revised for 2 presentation(s)
- Lidocaine Hydrochloride Injection: availability wording revised for 4 presentation(s)
2026-09-11
- Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Solution appeared on the FDA shortage list (being discontinued)
- Sodium Bicarbonate Injection: availability wording revised for 2 presentation(s)
2026-09-10
- Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection appeared on the FDA shortage list (being discontinued)
- Ifosfamide Injection: availability wording revised for 2 presentation(s)
- Rifampin Injection: availability wording revised for 1 presentation(s)
- Dextrose Monohydrate 10% Injection: availability wording revised for 1 presentation(s)
- Clindamycin Phosphate Injection: availability wording revised for 9 presentation(s)
- Midazolam Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Quinapril Hydrochloride Tablet: availability wording revised for 8 presentation(s)
- Promethazine Hydrochloride Injection: availability wording revised for 4 presentation(s)
- Atropine Sulfate Injection: availability wording revised for 2 presentation(s)
- Lisdexamfetamine Dimesylate Capsule: availability wording revised for 2 presentation(s)
- Sterile Water Irrigant: availability wording revised for 1 presentation(s)
2026-09-09
- Vecuronium Bromide Injection was removed from the FDA list (was being discontinued)
- Sumatriptan Nasal Spray was removed from the FDA list (was being discontinued)
2026-09-05
- Azelastine Hydrochloride; Fluticasone Propionate Nasal Spray was removed from the FDA list (was being discontinued)
- Methotrexate Sodium Injection: availability wording revised for 1 presentation(s)
- Carboplatin Injection: availability wording revised for 2 presentation(s)
- Morphine Sulfate Injection: availability wording revised for 1 presentation(s)
- Fentanyl Citrate Injection: availability wording revised for 1 presentation(s)
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet: availability wording revised for 4 presentation(s)
- Lidocaine Hydrochloride Injection: availability wording revised for 5 presentation(s)
- Ropivacaine Hydrochloride Injection: availability wording revised for 1 presentation(s)
2026-09-03
- Methotrexate Injection was removed from the FDA list (was being discontinued)
- Medroxyprogesterone Acetate Tablet appeared on the FDA shortage list (being discontinued)
- Insulin Glargine-aglr Injection appeared on the FDA shortage list (being discontinued)
- Insulin Lispro Protamine and Insulin Lispro Injection appeared on the FDA shortage list (being discontinued)
- Palovarotene Capsule appeared on the FDA shortage list (being discontinued)
- Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution appeared on the FDA shortage list (being discontinued)
- Triamcinolone Hexacetonide Injection: availability wording revised for 1 presentation(s)
- Methotrexate Sodium Injection: availability wording revised for 5 presentation(s)
- Hydromorphone Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Midazolam Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Rocuronium Bromide Injection: availability wording revised for 2 presentation(s)
- Glycerol Phenylbutyrate Oral Liquid appeared on the FDA shortage list (being discontinued)
- Ifosfamide Injection: availability wording revised for 1 presentation(s)
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet: availability wording revised for 2 presentation(s)
- Methylphenidate Hydrochloride Tablet, Extended Release: availability wording revised for 1 presentation(s)
- Fentanyl Citrate Injection: availability wording revised for 1 presentation(s)
- Metoprolol Succinate Tablet, Extended Release appeared on the FDA shortage list (being discontinued)
2026-08-28
- Pentostatin Injection appeared on the FDA shortage list (in shortage)
- Peginterferon alfa-2a Injection: availability wording revised for 2 presentation(s)
- Peginterferon alfa-2a Injection: in shortage → resolved
- Albuterol Sulfate Solution: availability wording revised for 3 presentation(s)
- Albuterol Sulfate Solution: in shortage → resolved
- Dobutamine Hydrochloride Injection: availability wording revised for 2 presentation(s)
- Liraglutide Injection: availability wording revised for 1 presentation(s)
- Dopamine Hydrochloride Injection: availability wording revised for 2 presentation(s)
2026-08-27
- Rifampin Injection: availability wording revised for 1 presentation(s)
- Lorazepam Injection: availability wording revised for 1 presentation(s)
- Hydromorphone Hydrochloride Injection: availability wording revised for 4 presentation(s)
- Dextrose Monohydrate 5% Injection: availability wording revised for 1 presentation(s)
- Carboplatin Injection: availability wording revised for 4 presentation(s)
- Meperidine Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection: availability wording revised for 1 presentation(s)
- Mesalamine Capsule, Extended Release appeared on the FDA shortage list (being discontinued)
- Lisdexamfetamine Dimesylate Capsule: availability wording revised for 1 presentation(s)
- Lidocaine Hydrochloride Injection: availability wording revised for 6 presentation(s)
- Rocuronium Bromide Injection: availability wording revised for 3 presentation(s)
- Dopamine Hydrochloride Injection: availability wording revised for 1 presentation(s)
- Midazolam Hydrochloride Injection: availability wording revised for 6 presentation(s)
- Morphine Sulfate Injection: availability wording revised for 2 presentation(s)
- Heparin Sodium Injection: availability wording revised for 1 presentation(s)
- Epinephrine Bitartrate, Lidocaine Hydrochloride Injection: availability wording revised for 5 presentation(s)
- Furosemide Injection: availability wording revised for 1 presentation(s)
2026-08-26
- Hydrocortisone Sodium Succinate Injection was removed from the FDA list (was resolved)
- Disopyramide Phosphate Capsule, Extended Release appeared on the FDA shortage list (being discontinued)
- Liraglutide Injection: availability wording revised for 2 presentation(s)
- Desmopressin Acetate Spray: availability wording revised for 1 presentation(s)
- Methylprednisolone Acetate Injection: availability wording revised for 1 presentation(s)
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.